Clinical Trial Update: A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated how multiple doses of enzalutamide affect the pharmacokinetics of digoxin and rosuvastatin, substrates of P-glycoprotein and BCRP, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DIGOXIN (Digoxin)
• Enzalutamide (enzalutamide)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED